Department of Structural and Chemical Biology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1677, New York, NY 10029-6574, USA.
J Med Chem. 2009 Aug 27;52(16):5207-16. doi: 10.1021/jm9005252.
The recent availability in the literature of new crystal structures of inactive G-protein coupled receptors (GPCRs) prompted us to study the extent to which these crystal structures constitute an advantage over the former prototypic rhodopsin template for homology modeling of the transmembrane (TM) region of human class A GPCRs. Our results suggest that better templates than those currently available are required by the majority of these GPCRs to generate homology models that are accurate enough for simple virtual screening aimed at computer-aided drug discovery. Thus, we investigated: (1) which class A GPCRs would have the highest impact as potential templates for homology modeling of other GPCRs, if their structures were solved, and (2) the extent to which multiple-template homology modeling (using all currently available GPCR crystal structures) provides an improvement over single-template homology modeling, as evaluated by the accuracy of rigid protein-flexible ligand docking on these models.
文献中最近出现了新的非活性 G 蛋白偶联受体 (GPCR) 的晶体结构,这促使我们研究这些晶体结构在多大程度上优于以前的典型视紫红质模板,用于同源建模人类 A 类 GPCR 的跨膜 (TM) 区域。我们的研究结果表明,对于大多数 GPCR 来说,需要比目前可用的更好的模板,才能生成足够准确的同源模型,以便进行简单的虚拟筛选,从而进行计算机辅助药物发现。因此,我们研究了:(1) 如果这些结构得到解决,哪些 A 类 GPCR 作为同源建模其他 GPCR 的潜在模板具有最高的影响力,以及 (2) 通过对这些模型上刚性蛋白-柔性配体对接的准确性进行评估,多模板同源建模 (使用所有当前可用的 GPCR 晶体结构) 在多大程度上优于单模板同源建模。